Telemedicine for Urologic Care in Rural Nigeria
Launched by UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · May 8, 2025
Trial Information
Current as of July 04, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial, called "Telemedicine for Urologic Care in Rural Nigeria," is designed to find out if using telemedicine—where patients consult with doctors through video calls—can help improve access to urologic care in rural areas of Nigeria. The study will involve two groups of adults living in rural Kaduna State. One group will meet with healthcare providers in person, while the other group will connect with doctors via telemedicine. Researchers will look at how well telemedicine works in helping patients get the care they need and will also gather feedback from participants about their satisfaction with the care they received.
To participate in this trial, you need to be at least 18 years old and live in rural Kaduna State. You should have a urologic issue, which means a problem related to your urinary system or male reproductive organs, but you should not be facing a urologic emergency. The trial is not yet open for recruitment, but once it is, eligible participants can expect to receive either in-person or virtual consultations for their urologic concerns and share their experiences through surveys.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults (at least 18 years old, any gender) that reside in rural Kaduna State.
- • Present to primary clinics with an active urologic chief complaint(s), either surgical or non-surgical in nature.
- Exclusion Criteria:
- • Children (\<18 years old).
- • Individuals who do not live in rural Kaduna State localities.
- • Those experiencing urologic emergencies.
- • Those who do not present with any urologic chief complaints defined as the primary reason the patient is seeking medical care.
About University Of California, San Francisco
The University of California, San Francisco (UCSF) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a focus on translating scientific discoveries into effective therapies, UCSF collaborates with a diverse array of stakeholders, including healthcare professionals, industry partners, and patient communities. The university's research programs emphasize interdisciplinary approaches and leverage cutting-edge technology to address complex medical challenges. As a sponsor of clinical trials, UCSF is dedicated to maintaining the highest standards of ethical conduct and scientific rigor, ensuring the safety and well-being of participants while contributing to the broader medical knowledge base.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Zaria, Kaduna, Nigeria
Patients applied
Trial Officials
David Bayne, MD
Principal Investigator
University of California, San Francisco
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported